Medicus Pharma Ltd. - Common Stock (NQ:MDCX)

0.1562 +0.0041 (+2.70%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 16, 2026 Add to My Watchlist

Price and Volume

Volume	3,219,107
Open	0.1501
Bid (Size)	0.1540 (1,800)
Ask (Size)	0.1588 (1,400)
Prev. Close	0.1521
Today's Range	0.1501 - 0.1598
52wk Range	0.1440 - 3.050
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Unusual volume stocks are being observed in Thursday's session. ↗

September 10, 2026

Via Chartmill

Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead Development Dose

September 10, 2026

CSR provides a clinical foundation for the Company’s recently announced capital-efficient focus on FDA-authorized Gorlin Syndrome NDA-enabling development program while supporting partnership...

From Medicus Pharma Ltd

Via GlobeNewswire

Performance

YTD	-90.2%	-90.2%
1 Month	-39.9%	-39.9%
3 Month	-53.4%	-53.4%
6 Month	-68.6%	-68.6%
1 Year	-93.7%	-93.7%

More News

Unusual volume stocks in Tuesday's session ↗

September 08, 2026

Via Chartmill

Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company

September 08, 2026

From Medicus Pharma Ltd

Via GlobeNewswire

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

September 03, 2026

Via Chartmill

Check out the stocks that are attracting the most attention and driving market activity. ↗

September 03, 2026

Via Chartmill

Thursday's session: top gainers and losers ↗

September 03, 2026

Via Chartmill

Gapping stocks in Thursday's session ↗

September 03, 2026

Via Chartmill

Wondering what's happening in today's pre-market session? ↗

September 03, 2026

Via Chartmill

Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

August 12, 2026

From Medicus Pharma Ltd

Via ACCESS Newswire

Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom

August 03, 2026

From Medicus Pharma Ltd

Via GlobeNewswire

Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis

July 31, 2026

From Medicus Pharma Ltd

Via GlobeNewswire

Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome

July 27, 2026

From Medicus Pharma Ltd

Via GlobeNewswire

New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings

July 25, 2026

From New to The Street

Via ACCESS Newswire

Top movers in Friday's after hours session ↗

July 24, 2026

Via Chartmill

Medicus Pharma Receives Positive FDA Feedback and Central IRB Approval for Optimized Phase 2 Teverelix® Novel Study in Acute Urinary Retention

July 16, 2026

From Medicus Pharma Ltd

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 13, 2026

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Monday? ↗

July 13, 2026

Via Chartmill

New to The Street Show #760 Airs Tonight on Bloomberg Television Across the U.S. on Independence Day Featuring Sullivan & Cromwell’s Frank Aquila, Medicus Pharma, PetVivo, FreeCast and YY Group

July 04, 2026

From New to The Street

Via ACCESS Newswire

Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026

June 22, 2026

From Medicus Pharma Ltd

Via GlobeNewswire

New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA

June 20, 2026

From New to The Street

Via ACCESS Newswire

Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome

June 15, 2026

From Medicus Pharma Ltd

Via GlobeNewswire

New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA

June 12, 2026

Via ACCESS Newswire

Medicus Pharma Initiates Groundbreaking PRECISION-E2 Phase 2a Study of Teverelix® in Endometriosis utilizing the Emirati Genome Program

June 11, 2026

From Medicus Pharma Ltd

Via GlobeNewswire

Graphene Manufacturing (OTCQX: GMGMF) (TSXV: GMG) Showcases Next-Generation Energy Storage and Graphene Innovation on Bloomberg TV – See INHD, SUNE, TDIC, DOSE Inside

June 08, 2026

Via AB Newswire

Frequently Asked Questions

Is Medicus Pharma Ltd. - Common Stock publicly traded?

Yes, Medicus Pharma Ltd. - Common Stock is publicly traded.

What exchange does Medicus Pharma Ltd. - Common Stock trade on?

Medicus Pharma Ltd. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Medicus Pharma Ltd. - Common Stock?

The ticker symbol for Medicus Pharma Ltd. - Common Stock is MDCX on the Nasdaq Stock Market

What is the current price of Medicus Pharma Ltd. - Common Stock?

The current price of Medicus Pharma Ltd. - Common Stock is 0.1562

When was Medicus Pharma Ltd. - Common Stock last traded?

The last trade of Medicus Pharma Ltd. - Common Stock was at 09/16/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.